<DOC>
	<DOCNO>NCT01791075</DOCNO>
	<brief_summary>The purpose study compare Tan EndoGlide new Endoserter injector term damage donor corneal endothelium compare endothelial cell loss 1 month , 3 month , 6 month , 1 year post DSAEK ( Descemet 's Stripping Automated Endothelial Keratoplasty ) surgery . There data compare two injector .</brief_summary>
	<brief_title>Comparing Endoglide Endoserter DSAEK Graft Insertion</brief_title>
	<detailed_description>Descemet 's stripping automate endothelial keratoplasty ( DSAEK ) widely perform method corneal transplantation . It consider standard care treatment endothelial cell dysfunction . The advantage technique include faster visual rehabilitation , decrease risk allograft rejection , preservation corneal tectonic strength , stable refraction , reduce irregular astigmatism , less suture complication . The standard care Toronto Western Hospital Dr. Rootman 's Dr. Slomovic 's patient corneal endothelial disease perform DSAEK surgery Tan Endoglide insertion donor graft . Other surgeon Toronto Western Hospital use either Busin glide specifically design forceps insertion donor graft part standard care . Still others advocate use suture pull-through technique . There significant disagreement literature regard DSAEK insertion technique best preserve donor endothelium . Some investigator report good result forceps suture , others caution fold . The less traumatic insertion endothelium , good long term survival corneal transplant . In addition , surgeon also debate whether large- small-incision DSAEK good graft 's long-term viability , propensity postoperative dislocation , ease insertion OR . The propose advantage Tan EndoGlide include consistent reliable delivery corneal donor small incision minimal endothelial loss . The advantage small-incision DSAEK , provide stable wound postoperatively , sutureless surgery , speed , convenience combine procedure standard phacoemulsification . Balancing attractiveness small-incision DSAEK concern endothelial injury donor fold forceps compression , Endosaver ( Ocular Systems , Inc. , Winston-Salem , NC ) novel DSAEK injector device , recently introduce . It allow surgeon insert unfolded tissue without forceps 4-mm clear corneal incision . Both device approve use Health Canada Class 1 device ( http : //www.angioedupro.com/Sharpoint/index.php ? seek=394 ) . Recently , result randomise prospective study conduct Dr. D. Tan ( inventor Tan EndoGlide ) publish . In study effect endothelial cell count use Tan EndoGlide evaluate . The investigator report 15.6 % endothelial cell loss 12 month DSAEK surgery . There publish study regard Endosaver injector , nevertheless , preliminary result indicate poor outcome ( 30 % cell loss one month ) . No study compare two device regard endothelial cell loss report far . The purpose study compare Tan EndoGlide new Endosaver injector term damage donor corneal endothelium compare endothelial cell loss 1 month , 3 month , 6 month , 1 year postoperatively . Our study would involve prospectively examine total 42 subject ( 21 eye Tan EndoGlide 21 eye Endosaver injector ) compare endothelial cell loss visual outcomes group .</detailed_description>
	<mesh_term>Fuchs ' Endothelial Dystrophy</mesh_term>
	<criteria>Patients present corneal decompensation require DSAEK without cataract surgery visual rehabilitation . Clinical diagnosis include endothelial cell dysfunction secondary Fuchs endothelial dystrophy , pseudophakic aphakic bullous keratopathy , fail penetrate keratoplasty DSAEK , iridocorneal endothelial syndrome trauma . Ability understand nature procedure give full inform consent . Patients able comply standard DSAEK followup protocol Toronto Western Hospital . Patients late stage corneal decompensation stromal scar unsuitable DSAEK therefore require penetrate keratoplasty . Patients complex anterior segment pathology preclude successful DSAEK procedure . Patients give full inform consent participate trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>DSAEK</keyword>
	<keyword>Tan Endoglide</keyword>
	<keyword>Endosaver/Endoserter</keyword>
</DOC>